Document Detail


Assessment of peripheral endothelial-dependent vasodilatation within the first year after heart transplantation.
MedLine Citation:
PMID:  19332254     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Peripheral endothelial dysfunction (ED) has been found in patients with severe heart failure. Whether ED improves after heart transplantation (HTx) is still a matter of controversy. METHODS: Forearm endothelium-dependent vasoreactivity was assessed in 40 patients after HTx. Flow-mediated vasodilatation (FMD) was measured by high-resolution brachial artery ultrasound to assess endothelial function at 1, 6, and 12 months after HTx. Cardiac allograft vasculopathy (CAV) was assessed by coronary angiography at 1 and 12 months and by intravascular ultrasound (IVUS) at 1 year. RESULTS: Mean FMD at 1 month was 1.9% +/- 2.6%, improving to 3.3% +/- 3.2% at 6 months (p < 0.005) and to 5.1% +/- 3.4% at 1 year (p < 0.0001). FMD was significantly impaired in 33 patients (82%) at 1 month, in 27 (67%) at 6 months, and in 19 (47%) at 1 year after HTx. CAV was diagnosed by IVUS in 19 patients (63%) at 1 year. Patients without peripheral ED at 1 month had lower incidence of increased intimal thickness of 0.5 mm or more at 1 year after HTx (20% vs 75%, p < 0.01). CONCLUSIONS: Impairment of peripheral FMD was highly prevalent soon after HTx and was present in nearly 50% of patients at 1 year. Patients without peripheral ED at 1 month were associated with lower probability of CAV. Although more studies are needed, the evaluation of peripheral endothelial function at 1 month after HTx could be potentially useful to identify patients at lower risk of CAV.
Authors:
Eulalia Roig; Alfredo Cuppoletti; Mónica Masotti; Ricardo Kianco; Isabel Vallejos; Marta Sitges; José Ortiz; Félix Pérez-Villa
Related Documents :
23647644 - Results of the wirk prospective, non-interventional observational study of recombinant ...
8629674 - Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, pr...
7671924 - The long term prognosis of infective endocarditis.
22858894 - Initial experience in ablation of typical atrial flutter using a novel three-dimensiona...
2071644 - Total replacement for post-traumatic arthritis of the elbow.
7911664 - Treatment of refractory rheumatoid arthritis with a chimeric anti-cd4 monoclonal antibo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation     Volume:  28     ISSN:  1557-3117     ISO Abbreviation:  J. Heart Lung Transplant.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-31     Completed Date:  2009-09-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102703     Medline TA:  J Heart Lung Transplant     Country:  United States    
Other Details:
Languages:  eng     Pagination:  299-304     Citation Subset:  IM    
Affiliation:
Institut Clínic del Torax, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. eroig@clinic.ub.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Brachial Artery / ultrasonography
Cytokines / blood
Electrocardiography
Endothelium, Vascular / physiology*
Female
Follow-Up Studies
Forearm / blood supply
Heart Diseases / classification,  surgery
Heart Transplantation / physiology*
Humans
Male
Middle Aged
Time Factors
Tumor Necrosis Factor-alpha / blood
Vasodilation / physiology*
Chemical
Reg. No./Substance:
0/Cytokines; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of gestational trophoblastic neoplasia.
Next Document:  Anti-MICA antibodies are related to adverse outcome in heart transplant recipients.